...
首页> 外文期刊>Journal of Cosmetics, Dermatological Sciences and Applications >Anti-Aging Efficacy of a New Alendronate-Pravastatin Cosmetic Combination: A Randomized Double Blind Comparative Study
【24h】

Anti-Aging Efficacy of a New Alendronate-Pravastatin Cosmetic Combination: A Randomized Double Blind Comparative Study

机译:新型阿仑膦酸酯-普伐他汀化妆品组合的抗衰老功效:随机双盲比较研究。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Progeria is a rare genetic disease that causes accelerated aging and death in children at a mean age of 13.5 years. An?aminobisphosphonate-statin combination has been shown to reduce the toxicity of the mutated protein, progerin, in progeria patient cell cultures and in a mouse model of the disease. This combination is currently being tested in a European Therapeutic Trial for progeria in Marseille (ClinicalTrials.gov identifier NCT00731016). Progerin has been shown to be produced by skin cells during physiological aging. The objective of this study was to assess the efficiency of a new and original cosmetic formulation containing alendronate and pravastatin sodium salts, reduce crow’s feet wrinkles, and cheek hollow in a double blind, randomized and placebo controlled comparative study. Three cosmetic preparations were evaluated using Fast Optical in vivo Topometry of human Skin (FOITS): one containing sodium alendronate and sodium pravastatin, a placebo, and a commercial anti-aging product. Fifty-seven female and twenty-five male volunteers between 51 and 71-year-old were selected. Each subject tested two of the three products once a day, in the evening, by spreading each selected product on one side of the face. Skin micro-relief was analyzed at 0, 28, 56 and 84 days. Statistical analysis of 7 clinical qualitative (left or right side of face, gender, and 3 skin types) and 6 quantitative parameters (age, weight at each test time, wrinkle clinical grade at inclusion time) showed no statistical differences between the three tested products. In contrast, most of the 8 quantitative FOITS parameters describing skin micro-relief were statistically improved by the alendronate-pravastatin combination compared to the placebo or to the commercial anti-aging product. A cosmetic preparation containing alendronate and pravastatin sodium salts exhibited anti-aging effects by reducing crow’s feet wrinkles and restoring cheek volume.
机译:早衰是一种罕见的遗传疾病,可导致平均年龄为13.5岁的儿童加速衰老和死亡。已显示氨基二膦酸盐-他汀类药物的组合在早衰患者的细胞培养物中和在该疾病的小鼠模型中降低了突变蛋白progerin的毒性。目前,该组合正在马赛针对早衰的欧洲治疗试验中进行测试(ClinicalTrials.gov标识为NCT00731016)。早衰素已显示在生理衰老过程中由皮肤细胞产生。这项研究的目的是在一项双盲,随机和安慰剂对照的比较研究中评估含有阿仑膦酸和普伐他汀钠盐的新型化妆品配方的功效,减少鱼尾纹和脸颊凹陷。使用人体皮肤的快速光学体内拓扑结构(FOITS)对三种化妆品制剂进行了评估:一种包含阿仑膦酸钠和普伐他汀钠,一种安慰剂和一种商业抗衰老产品。选择了51至71岁之间的57位女性志愿者和25位男性志愿者。每个受试者每天晚上在天上一次测试三种产品中的两种,方法是将每种选择的产品散布在面部的一侧。在0、28、56和84天对皮肤微浮雕进行了分析。对7种临床定性(面部,左侧和右侧,性别和3种皮肤类型)和6种定量参数(年龄,每次测试时的体重,入选时的皱纹临床等级)的统计分析表明,三种测试产品之间没有统计学差异。相比之下,与安慰剂或商业抗衰老产品相比,阿仑膦酸-普伐他汀联合使用在统计学上描述皮肤微浮雕的8个定量FOITS参数中的大多数在统计学上得到了改善。含有阿仑膦酸钠和普伐他汀钠盐的化妆品制剂通过减少鱼尾纹和恢复脸颊体积显示出抗衰老的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号